GenSight Biologics
FranceEntry
–
Hold
–
Status
Active
Who owns GenSight Biologics?
GenSight Biologics is currently owned by Sofinnova Partners through Sofinnova Crossover Fund I (2018 vintage). Across its history, GenSight Biologics has been through 3 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
Sofinnova PartnersSofinnova Crossover Fund I · 2018 · VC
3 ownership periods · full history below
Key facts
Key takeaways
- ·Held by Sofinnova Partners since n/a.
- ·Average hold across 2 realized cycles: 3 years.
Ownership history
3 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2012 · 2016
Sofinnova PartnersActive
present · Sofinnova Crossover Fund I · 2018 · VC
More from Sofinnova Crossover Fund I
Other portfolio companies in the same fund.
UK
Sweden
DenmarkMore PE-backed in Biotech
Comparable biotech deals from other GPs.
USTrack GenSight Biologics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy GenSight Biologics?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on GenSight Biologics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue